Biomarker panel (TheraPrint) analyzed as a predictor of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Peter D. Beitsch
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
Femke De Snoo
Employment or Leadership Position - Agendia
Justine Peeters
Employment or Leadership Position - Agendia
Pat W. Whitworth
No relevant relationships to disclose